Both in Biotechnology
Inhibrx Biosciences vs Maze Therapeutics
Over the past year INBX returned +224.5% and MAZE returned +7.2%; their daily moves had a correlation of 0.14.
INBX +224.5% MAZE +7.2%Growth of $1, one year, split-adjusted
| Metric | INBX | MAZE |
|---|---|---|
| Price | $104.83 | $27.02 |
| Market cap | $1.54B | $1.50B |
| Today | +3.07% | +0.63% |
| 1 month | −15.1% | −1.5% |
| 6 months | +75.1% | −6.9% |
| Year to date | +32.7% | −34.8% |
| 1 year | +220.8% | +0.1% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 75.0× |
| Net cash | -$42.9M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | 67.6% | 66.4% |
| Short % of float | 36.5% | 14.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).